Resveratrol‐loaded nanomedicines for cancer applications

Abstract Background Resveratrol (3, 5, 4′‐trihydroxystilbene), a natural polyphenol and phytoalexin, has drawn considerable attention in the past decade due to its wide variety of therapeutic activities such as anticancer, anti‐inflammatory, and antioxidant properties. However, its poor water solubi...

Full description

Bibliographic Details
Main Authors: Manjusha Annaji, Ishwor Poudel, Sai H. S. Boddu, Robert D. Arnold, Amit K. Tiwari, R. Jayachandra Babu
Format: Article
Language:English
Published: Wiley 2021-06-01
Series:Cancer Reports
Subjects:
Online Access:https://doi.org/10.1002/cnr2.1353
_version_ 1818669219115433984
author Manjusha Annaji
Ishwor Poudel
Sai H. S. Boddu
Robert D. Arnold
Amit K. Tiwari
R. Jayachandra Babu
author_facet Manjusha Annaji
Ishwor Poudel
Sai H. S. Boddu
Robert D. Arnold
Amit K. Tiwari
R. Jayachandra Babu
author_sort Manjusha Annaji
collection DOAJ
description Abstract Background Resveratrol (3, 5, 4′‐trihydroxystilbene), a natural polyphenol and phytoalexin, has drawn considerable attention in the past decade due to its wide variety of therapeutic activities such as anticancer, anti‐inflammatory, and antioxidant properties. However, its poor water solubility, low chemical stability, and short biological half‐life limit its clinical utility. Recent findings Nanoparticles overcome the limitations associated with conventional chemotherapeutic drugs, such as limited availability of drugs to the tumor tissues, high systemic exposures, and consequent toxicity to healthy tissues. This review focuses on the physicochemical properties of resveratrol, the therapeutic potential of resveratrol nano‐formulations, and the anticancer activity of resveratrol encapsulated nanoparticles on various malignancies such as skin, breast, prostate, colon, liver, ovarian, and lung cancers (focusing on both in vitro and in vivo studies). Conclusions Nanotechnology approaches have been extensively utilized to achieve higher solubility, improved oral bioavailability, enhanced stability, and controlled release of resveratrol. The resveratrol nanoparticles have markedly enhanced its anticancer activity both in vitro and in vivo, thus considering it as a potential strategy to fight various cancers.
first_indexed 2024-12-17T06:48:44Z
format Article
id doaj.art-4d80c3d7e08947db80794ebe90d60426
institution Directory Open Access Journal
issn 2573-8348
language English
last_indexed 2024-12-17T06:48:44Z
publishDate 2021-06-01
publisher Wiley
record_format Article
series Cancer Reports
spelling doaj.art-4d80c3d7e08947db80794ebe90d604262022-12-21T21:59:39ZengWileyCancer Reports2573-83482021-06-0143n/an/a10.1002/cnr2.1353Resveratrol‐loaded nanomedicines for cancer applicationsManjusha Annaji0Ishwor Poudel1Sai H. S. Boddu2Robert D. Arnold3Amit K. Tiwari4R. Jayachandra Babu5Department of Drug Discovery and Development Auburn University Auburn Alabama USADepartment of Drug Discovery and Development Auburn University Auburn Alabama USADepartment of Pharmaceutical Sciences, College of Pharmacy and Health Sciences Ajman University Ajman United Arab EmiratesDepartment of Drug Discovery and Development Auburn University Auburn Alabama USADepartment of Pharmacology and Experimental Therapeutics, College of Pharmacy & Pharmaceutical Sciences University of Toledo Toledo Ohio USADepartment of Drug Discovery and Development Auburn University Auburn Alabama USAAbstract Background Resveratrol (3, 5, 4′‐trihydroxystilbene), a natural polyphenol and phytoalexin, has drawn considerable attention in the past decade due to its wide variety of therapeutic activities such as anticancer, anti‐inflammatory, and antioxidant properties. However, its poor water solubility, low chemical stability, and short biological half‐life limit its clinical utility. Recent findings Nanoparticles overcome the limitations associated with conventional chemotherapeutic drugs, such as limited availability of drugs to the tumor tissues, high systemic exposures, and consequent toxicity to healthy tissues. This review focuses on the physicochemical properties of resveratrol, the therapeutic potential of resveratrol nano‐formulations, and the anticancer activity of resveratrol encapsulated nanoparticles on various malignancies such as skin, breast, prostate, colon, liver, ovarian, and lung cancers (focusing on both in vitro and in vivo studies). Conclusions Nanotechnology approaches have been extensively utilized to achieve higher solubility, improved oral bioavailability, enhanced stability, and controlled release of resveratrol. The resveratrol nanoparticles have markedly enhanced its anticancer activity both in vitro and in vivo, thus considering it as a potential strategy to fight various cancers.https://doi.org/10.1002/cnr2.1353cancerin vitroin vivonanoparticlespolyphenolresveratrol
spellingShingle Manjusha Annaji
Ishwor Poudel
Sai H. S. Boddu
Robert D. Arnold
Amit K. Tiwari
R. Jayachandra Babu
Resveratrol‐loaded nanomedicines for cancer applications
Cancer Reports
cancer
in vitro
in vivo
nanoparticles
polyphenol
resveratrol
title Resveratrol‐loaded nanomedicines for cancer applications
title_full Resveratrol‐loaded nanomedicines for cancer applications
title_fullStr Resveratrol‐loaded nanomedicines for cancer applications
title_full_unstemmed Resveratrol‐loaded nanomedicines for cancer applications
title_short Resveratrol‐loaded nanomedicines for cancer applications
title_sort resveratrol loaded nanomedicines for cancer applications
topic cancer
in vitro
in vivo
nanoparticles
polyphenol
resveratrol
url https://doi.org/10.1002/cnr2.1353
work_keys_str_mv AT manjushaannaji resveratrolloadednanomedicinesforcancerapplications
AT ishworpoudel resveratrolloadednanomedicinesforcancerapplications
AT saihsboddu resveratrolloadednanomedicinesforcancerapplications
AT robertdarnold resveratrolloadednanomedicinesforcancerapplications
AT amitktiwari resveratrolloadednanomedicinesforcancerapplications
AT rjayachandrababu resveratrolloadednanomedicinesforcancerapplications